NDDPX 08

Drug Profile

NDDPX 08

Alternative Names: Bromocriptine - Neugen Pharma KK; NDDPX08

Latest Information Update: 23 Dec 2010

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Neugen Pharma
  • Class Antihyperglycaemics; Antiparkinsonians; Ergolines; Ergotamines; Infertility therapies
  • Mechanism of Action Dopamine D2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Clinical Phase Unknown Amyotrophic lateral sclerosis

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
  • 13 Nov 2010 Pharmacodynamics data from a preclinical trial in Amyotrophic lateral sclerosis presented at the 40th Annual Meeting of the Society for Neuroscience (SFN-2010)
  • 13 Nov 2010 Clinical trials in Amyotrophic lateral sclerosis in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top